AU4961499A - 5-HT1f agonists - Google Patents
5-HT1f agonistsInfo
- Publication number
- AU4961499A AU4961499A AU49614/99A AU4961499A AU4961499A AU 4961499 A AU4961499 A AU 4961499A AU 49614/99 A AU49614/99 A AU 49614/99A AU 4961499 A AU4961499 A AU 4961499A AU 4961499 A AU4961499 A AU 4961499A
- Authority
- AU
- Australia
- Prior art keywords
- ht1f agonists
- ht1f
- agonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9087298P | 1998-06-26 | 1998-06-26 | |
US60090872 | 1998-06-26 | ||
US9495798P | 1998-07-31 | 1998-07-31 | |
US60094957 | 1998-07-31 | ||
PCT/US1999/014502 WO2000000490A2 (en) | 1998-06-26 | 1999-06-24 | 5-ht1f agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4961499A true AU4961499A (en) | 2000-01-17 |
Family
ID=26782729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49614/99A Abandoned AU4961499A (en) | 1998-06-26 | 1999-06-24 | 5-HT1f agonists |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4961499A (en) |
WO (1) | WO2000000490A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7211594B2 (en) | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
US6897231B2 (en) | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
ATE377598T1 (en) | 2001-01-22 | 2007-11-15 | Sankyo Co | COMPOUNDS SUBSTITUTED BY BICYCLIC AMINO GROUPS |
ATE380558T1 (en) * | 2001-01-29 | 2007-12-15 | Serono Lab | USE OF IL-18 INHIBITORS TO TREAT AND/OR PREVENT HEART DISEASE |
EP1380576B1 (en) | 2001-04-16 | 2009-11-25 | Eisai R&D Management Co., Ltd. | 1h-indazole compounds inhibiting jnk |
TWI263497B (en) | 2002-03-29 | 2006-10-11 | Lilly Co Eli | Pyridinoylpiperidines as 5-HT1F agonists |
MXPA05011223A (en) | 2003-04-18 | 2006-01-26 | Lilly Co Eli | 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity. |
UA82711C2 (en) | 2003-09-12 | 2008-05-12 | Эли Лилли Энд Компани | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
JP2007516266A (en) | 2003-12-17 | 2007-06-21 | イーライ リリー アンド カンパニー | Substituted (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl compounds as 5-HT1F agonists |
CA2795062A1 (en) | 2010-04-02 | 2011-10-06 | Colucid Pharmaceuticals, Inc. | Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists |
CN103044316A (en) * | 2013-01-23 | 2013-04-17 | 石家庄学院 | Method for preparing 1,4-dihydropyridine by using imidazole ionic liquid as catalyst |
AR119319A1 (en) | 2019-07-09 | 2021-12-09 | Lilly Co Eli | PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-IL]-BENZAMIDE HEMISUCCINATE AND PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-IL]-BENZAMIDE |
CN115872916A (en) * | 2022-11-30 | 2023-03-31 | 华东理工大学 | Method for synthesizing indole-5-formaldehyde compound based on microchannel reactor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
ATE156823T1 (en) * | 1990-06-07 | 1997-08-15 | Zeneca Ltd | THERAPEUTIC HETEROCYCLIC COMPOUNDS |
GB9226532D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
US5607960A (en) * | 1993-04-22 | 1997-03-04 | Pfizer Inc. | Indole derivatives as 5-HT1-like agonists for use in migraine |
JPH10501212A (en) * | 1994-05-19 | 1998-02-03 | メルク シヤープ エンド ドーム リミテツド | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-HT <1D> -alpha agonists |
US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
NZ305166A (en) * | 1995-03-20 | 1998-12-23 | Lilly Co Eli | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles; preparation and medicaments |
-
1999
- 1999-06-24 AU AU49614/99A patent/AU4961499A/en not_active Abandoned
- 1999-06-24 WO PCT/US1999/014502 patent/WO2000000490A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000000490A3 (en) | 2003-04-17 |
WO2000000490A2 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5203999A (en) | Beta3-adrenergic receptor agonists | |
AU3485999A (en) | Neo-tryptophan | |
AU9392998A (en) | Pack-a-pillow | |
AU7128798A (en) | Substituted heteroaromatic 5-ht1f agonists | |
AU4961499A (en) | 5-HT1f agonists | |
AU3437799A (en) | City-car | |
AU3522399A (en) | Carvedilol-galenics | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU3253699A (en) | Myxochelines | |
HUP0004317A3 (en) | 5-ht1f agonists | |
AU5688499A (en) | Non-knotting line | |
AU5516599A (en) | Substituted 3-aryl-pyrazoles | |
AU8363398A (en) | Capotasto | |
IL144355A0 (en) | 5-ht1f agonists | |
AU5112699A (en) | 5-HT1f antagonists | |
AU2609599A (en) | Sensor-coupling | |
AU4511499A (en) | Substituted cyclooctadepsipeptides | |
AU3204999A (en) | Futureball | |
AU2069199A (en) | Codelets | |
AU4507899A (en) | Substituted n-aryl-o-alkyl-carbamates | |
AU1055399A (en) | Rollerboard | |
AU5223199A (en) | Bathtub-bathseat | |
AU9347498A (en) | Imidazotriazolopyrimidines | |
AU3347599A (en) | Aeromobile | |
AU2840799A (en) | 1-phosphanorbornadienes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |